Condition: Mania · Bipolar Disorder · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the efficacy and safety of adjunctive KarXT for the treatment of mania in participants with Bipolar-I Disorder.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Pillar Clinical Research - Bentonville | Bentonville, Arkansas, United States | Recruiting |
| Pillar Clinical Research- Little Rock | Little Rock, Arkansas, United States | Recruiting |
| Clinical Innovations, Inc. dba CITrials | Bellflower, California, United States | Recruiting |
| Inland Psychiatric Medical Group. | Chino, California, United States | Recruiting |
| Proscience Research Group | Culver City, California, United States | Recruiting |
| Omega Clinical Trials - La Habra | La Habra, California, United States | Recruiting |
| Catalina Research Institute, LLC | Montclair, California, United States | Recruiting |
| NRC Research Institute | Orange, California, United States | Recruiting |
| Clinical Innovations, Inc. dba CITrials | Riverside, California, United States | Recruiting |
| Velocity Clinical Research, Hallandale Beach | Hallandale, Florida, United States | Recruiting |
| South Florida Research Phase I-IV | Miami, Florida, United States | Recruiting |
| Health Synergy Clinical Research | West Palm Beach, Florida, United States | Recruiting |
+ 92 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07140913